Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.35 USD | -1.55% | -3.23% | -23.03% |
Apr. 01 | Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 26 | Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule | MT |
Financials (USD)
Sales 2022 | 557K | Sales 2023 | 184K | Capitalization | 6.21M |
---|---|---|---|---|---|
Net income 2022 | -10M | Net income 2023 | -5M | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 2.75M | Net cash position 2023 | 6.2M | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
1 day | -1.55% | ||
1 week | -3.23% | ||
Current month | -5.29% | ||
1 month | -9.41% | ||
3 months | -16.42% | ||
6 months | -11.93% | ||
Current year | -23.03% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 22-08-14 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 23-10-11 |
Brynner Chiam
BRD | Director/Board Member | - | 23-10-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 6.35 | -1.55% | 762 |
24-05-20 | 6.45 | +1.74% | 1,624 |
24-05-17 | 6.34 | -2.17% | 11,805 |
24-05-16 | 6.481 | -1.05% | 6,808 |
24-05-15 | 6.55 | -0.18% | 850 |
Delayed Quote Nasdaq, May 21, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-23.03% | 5.9M | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- TTNP Stock